ELA PHARMA

ela-pharma-logo

Ela Pharma specializes in the development of innovative drugs that address clinical conditions caused by necrosis. It bases the process of development of drugs on a platform for anti-necrosis technology. The prevention and treatment of necrosis is significant to the therapy of numerous pathological conditions and diseases. It bases its technolog on an approach that directly inhibits an intracellular proteolytic enzyme that plays a critical role in the regulation of necrosis pathway.

#SimilarOrganizations #Website #More

ELA PHARMA

Social Links:

Industry:
Biopharma Biotechnology Life Science Pharmaceutical

Founded:
2015-01-01

Address:
Tel Aviv, Tel Aviv, Israel

Country:
Israel

Website Url:
http://www.elapharma.com

Total Employee:
1+

Status:
Active

Contact:
+972 54-439-6331

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Mobile Non Scaleable Content Nginx


Similar Organizations

shanton-pharma-logo

Shanton Pharma

Shanton Pharma specializes in providing innovative therapies for addressing significant unmet medical needs.

Official Site Inspections

http://www.elapharma.com Semrush global rank: 6.66 M Semrush visits lastest month: 309

  • Host name: 106.89.215.35.bc.googleusercontent.com
  • IP address: 35.215.89.106
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "Ela Pharma"

ElaPharma Ltd | Inhibiting Necrosis

Contact Information. 16/6 Dulchin st , Tel-Aviv 6936006, Israel T 972-54-4396331 F 972-77-7117766See details»

Ela Pharma - Crunchbase Company Profile & Funding

Ela Pharma specializes in the development of innovative drugs that address clinical conditions caused by necrosis. It bases the process of development of โ€ฆSee details»

Ela Pharma - Company Profile - Tracxn

ElaPharma is developing antinectrotic therapies. They have developed an Anti-Necrosis Technology, which directly inhibits an intracellular proteolytic enzyme that plays a role in the โ€ฆSee details»

ELA PHARMA LTD Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for ELA PHARMA LTD of TEL AVIV-JAFFA, Central District. Get the latest business insights from Dun & Bradstreet.See details»

Ela Pharma - Overview, News & Similar companies | ZoomInfo.com

View Ela Pharma (www.elapharma.com) location in Tel Aviv, Israel , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»

Ela Pharma Ltd. | LinkedIn

Ela Pharma is driven to create novel therapeutics for better patient recovery and care, in the most pressing clinical applications such as organ preservation, retinal artery occlusion, acute ...See details»

Company Information - RocketReach

Ela Pharma is driven to create novel therapeutics for better patient recovery and care, in the most pressing clinical applications such as organ preservation, retinal artery occlusion, acute โ€ฆSee details»

Homepage02 | ElaPharma Ltd

Contact information 16/6 Aryeh Dulchen st , Tel-Aviv 69360, Israel T 972-54-4396331 F 972-77-7117766See details»

Ela Pharma - Foreign Startup | Startup Nation Finder

Ela Pharma is a biotechnology company developing innovative drugs designed to address clinical conditions caused by necrosis. The companys drug-development process is based on a new โ€ฆSee details»

ELA PHARMA LTD - explore.openaire.eu

Organization, country, ELA PHARMA LTDELA PHARMA LTD. toggle menu. close close menuSee details»

Ela Pharma Limited:Company Profile & Technical โ€ฆ

Ela Pharma Limited is headquartered in Israel . Ela Pharma Limited was founded in 2015. Ela Pharma Limited has a total of 23 patentsSee details»

Elapharma Ltd. - Overview, Competitors and Decision Makers

Elapharma Ltd.is headquartered in Israel, Tel Aviv-Yafo - Find employees, decision makers, competitors and company information. DataLead allows to search for B2B contacts and โ€ฆSee details»

Israeli researchers aim to find โ€˜cure for the incurableโ€™ to prolong ...

Apr 29, 2021 ElaPharma, which was founded in 2015, is developing a drug that would be administered in such cases to stop necrosis already in the ambulance, giving the patient a โ€ฆSee details»

Elapharma Company Profile | Denderleeuw, EAST ... - Dun

Find company research, competitor information, contact details & financial data for Elapharma of Denderleeuw, EAST-FLANDERS. Get the latest business insights from Dun & Bradstreet.See details»

Ela Pharma - Contacts, Employees, Board Members, Advisors

Ela Pharma specializes in the development of innovative drugs that address clinical conditions caused by necrosis.See details»

Elapharma Company Profile | Bruxelles, Belgium | Competitors ...

Elapharma. Get a D&B Hoovers Free Trial. Overview Company Description:? Industry: Health and Personal Care Retailers , Retail Trade , Drug stores and proprietary stores, nec, Orthopedic โ€ฆSee details»

New approach to the preservation of organs could buy medical โ€ฆ

May 15, 2020 The ELAPHARMA project, hosted by ElaPharma Ltd has come up with a new solution which, in the future, might help to preserve organs for longer. โ€œWe have addressed a โ€ฆSee details»

TGI/BIOVET CGT and Ela Pharma Announce Joint Development โ€ฆ

Jan 5, 2024 MIAMI, FL / ACCESSWIRE / January 5, 2024 / TGI Solar Power Group, Inc. (OTC Markets:TSPG), through its subsidiary BIOVET CGT, a veterinarian biotechnology company, โ€ฆSee details»

ElaPharma Ltd - DevelopmentAid

ElaPharma Ltd โ€” NGO from Israel, has experience with Horizon 2020 (2014 - 2020), it`s involved in Health sectorSee details»

ElaPharma and Professor Ilana Nathan: Nobel Prize candidate?

Nov 13, 2017 Her current mission is ElaPharma: anti-necrosis technology that would prevent cell death. This new drug defies all past scientific studies and conclusions that Necrosis cannot be โ€ฆSee details»

linkstock.net © 2022. All rights reserved